Market News AIOpen the app

ChronoScale is growing its AI projects and aims to make $1 billion a year by 2027.

DealRead the original at Benzinga
Good for CHRN

ChronoScale added AI contracts that support a path to $1 billion in yearly revenue during 2027, and sold Ekso Bionics to focus on AI. Reaching that pace depends on building sites, power, equipment, and suitable funding.

CHRN · ChronoScale Holdings Corp

AI read · Good for CHRN

The AI's read

The contracts give ChronoScale a clearer route to grow its AI infrastructure business, and the sale puts more attention on that work. Reaching the stated revenue pace depends on building sites, getting power and equipment, and raising money on acceptable terms. Those requirements could slow the plan.

Get alerts for CHRN

Follow ChronoScale Holdings Corp (CHRN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CHRN
Free on the App Store and Google Play, or on the web.